Peptibody Based on FGFR1-Binding Peptides From the FGF4 Sequence as a Cancer-Targeting Agent
Targeted therapies are a promising alternative to conventional chemotherapy, with an increasing number of therapeutics targeting specific molecular aberrancies in cancer cells. One of the emerging targets for directed cancer treatments is fibroblast growth factor receptors (FGFRs), which are known t...
Guardado en:
Autores principales: | Karolina Jendryczko, Jakub Rzeszotko, Mateusz Adam Krzyscik, Jakub Szymczyk, Jacek Otlewski, Anna Szlachcic |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/916c9edb3c4d499ab88c5169dc5b691f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
FGF/FGFR-Dependent Molecular Mechanisms Underlying Anti-Cancer Drug Resistance
por: Jakub Szymczyk, et al.
Publicado: (2021) -
Liposomes derivatized with multimeric copies of KCCYSL peptide as targeting agents for HER-2-overexpressing tumor cells
por: Ringhieri P, et al.
Publicado: (2017) -
Prevention of doxorubicin-induced cardiomyopathy using targeted MaFGF mediated by nanoparticles combined with ultrasound-targeted MB destruction
por: Tian XQ, et al.
Publicado: (2017) -
Peptide T7-modified polypeptide with disulfide bonds for targeted delivery of plasmid DNA for gene therapy of prostate cancer
por: Lu Y, et al.
Publicado: (2018) -
Peptide-Based Drug Delivery Systems
por: Dmitriy Berillo, et al.
Publicado: (2021)